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The diagnosis of HAM/TSP is based on criteria, as pro-
posed by the World Health Organization, revised in 1989.
This primarily relies on diagnosis through laboratory cri-
teria and an extensive list of neurological signs and symp-
toms. Consequentially HAM/TSP diagnosis is often
delayed or not confirmed, especially in countries with lim-
ited resources. There is strong evidence that high levels of
proviral load (PVL) are more frequently found in HAM/
TSP patients compared to asymptomatic carriers. Consid-
ering PVL as an additional diagnostic criterion for HAM/
TSP diagnosis may be useful in classifying the disease at an
earlier stage. However, there is yet to be a consensus on a
PVL threshold for differentiating HAM/TSP and asympto-
matic individuals. To further understand this critical cut-
off point, we have systematically searched scientific data-
bases and analysed data on HTLV-1 proviral loads in
HAM/TSP patients compared to asymptomatic carriers.
Median PVL data has been extracted from a multitude of
cohort studies from both endemic and non-endemic coun-
tries. In addition, we have evaluated the methodologies
used to measure proviral load, such as the amplified region
of the HTLV-1 genome, DNA sample source and number
of cells quantified. The analysis of these results may help to
determine a PVL that will distinguish HAM/TSP patients
from asymptomatic individuals. Observations on this
review, gives proposition to the need for an international,
cross-sectional study with standardized methodologies that
would provide a universal threshold that would finally
enable clinicians to distinguish HTLV-1 infection at the
different clinical stages through the use of a quantitative
marker.
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